Neurocrine Days Of Inventory On Hand from 2010 to 2024

NBIX Stock  USD 138.64  1.95  1.43%   
Neurocrine Biosciences Days Of Inventory On Hand yearly trend continues to be fairly stable with very little volatility. Days Of Inventory On Hand is likely to outpace its year average in 2024. During the period from 2010 to 2024, Neurocrine Biosciences Days Of Inventory On Hand regression line of annual values had r-squared of  0.08 and arithmetic mean of (2,190). View All Fundamentals
 
Days Of Inventory On Hand  
First Reported
2010-12-31
Previous Quarter
352.12846348
Current Value
369.73
Quarterly Volatility
4.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Neurocrine Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neurocrine Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 22.4 M, Interest Expense of 7.4 M or Selling General Administrative of 894.2 M, as well as many indicators such as Price To Sales Ratio of 6.48, Dividend Yield of 0.0 or PTB Ratio of 6.13. Neurocrine financial statements analysis is a perfect complement when working with Neurocrine Biosciences Valuation or Volatility modules.
  
Check out the analysis of Neurocrine Biosciences Correlation against competitors.
For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.

Latest Neurocrine Biosciences' Days Of Inventory On Hand Growth Pattern

Below is the plot of the Days Of Inventory On Hand of Neurocrine Biosciences over the last few years. It is Neurocrine Biosciences' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neurocrine Biosciences' overall financial position and show how it may be relating to other accounts over time.
Days Of Inventory On Hand10 Years Trend
Slightly volatile
   Days Of Inventory On Hand   
       Timeline  

Neurocrine Days Of Inventory On Hand Regression Statistics

Arithmetic Mean(2,190)
Geometric Mean752.29
Coefficient Of Variation(197.05)
Mean Deviation3,664
Median(0.61)
Standard Deviation4,314
Sample Variance18.6M
Range10.1K
R-Value0.29
Mean Square Error18.4M
R-Squared0.08
Significance0.29
Slope280.25
Total Sum of Squares260.6M

Neurocrine Days Of Inventory On Hand History

2024 369.73
2023 352.13
2022 552.22
2021 778.5
2020 1011.88
2019 852.72
2018 811.08

About Neurocrine Biosciences Financial Statements

Neurocrine Biosciences investors use historical fundamental indicators, such as Neurocrine Biosciences' Days Of Inventory On Hand, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Neurocrine Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 352.13  369.73 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Neurocrine Stock Analysis

When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.